Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study

Chlorprothixene is commonly used off‐label in low doses for sedative‐hypnotic purposes although it might carry a risk of cardiometabolic adverse events due to its pharmacodynamic profile. We investigated the risk of diabetes and major adverse cardiovascular events (MACE) with use of low‐dose chlorpr...

Descripción completa

Detalles Bibliográficos
Autores principales: Højlund, Mikkel, Wagner, Christina Blanner, Wesselhoeft, Rikke, Andersen, Kjeld, Fink‐Jensen, Anders, Hallas, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303779/
https://www.ncbi.nlm.nih.gov/pubmed/35122399
http://dx.doi.org/10.1111/bcpt.13711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303779/
https://www.ncbi.nlm.nih.gov/pubmed/35122399
http://dx.doi.org/10.1111/bcpt.13711

Ejemplares similares